IXICO awarded funding for digital platform to support people with cognitive impairment and dementia
SBRI Healthcare, an NHS England funded initiative to develop innovative products that address unmet health needs, today announced the companies that will share £1.3 million funding to develop products that can significantly impact the increasing pressures being put on urgent and emergency care services.
The number of attendances at A&E has risen significantly in the last decade putting pressure on urgent and emergency care services and increasing waiting times. According to the Kings Fund, 21.7 million visited A&E in 2013/14, a greater than 30% rise in the last decade. More than 70% of hospital bed days are occupied by A&E admissions and 80% of A&E admissions who stay for more than two weeks are patients aged over 65.
A total of 14 companies, including one in the UCLPartners region, were selected to develop their innovations in three key areas: resource planning, co-ordinating admissions and preventing admissions.
With an average award of £96,500 each, the successful companies (and supporting Academic Health Science Networks) are:
- 365Response (Yorkshire & Humber AHSN)
- Snap40 (Scotland), SA IP (West of England AHSN)
- Cambridge Clinical Management Analytics (Eastern AHSN)
- Ubisense Ltd (Eastern AHSN)
- Ubisense Ltd (Eastern AHSN)
- Biovici (Wales)
- IXICO (UCLPartners)
- Kernow Health Solutions (South West AHSN)
- Serket Technology (Eastern AHSN)
- Mologic (East Midlands AHSN)
- Microbiosensor (Greater Manchester AHSN)
- Renephra (Greater Manchester AHSN)
- Careflow Connect (West of England AHSN)
- Farewill (Imperial College AHSN)
The SBRI awarded funding to IXICO for MyBrainBook; a digital platform that allows patients with cognitive impairment and dementia to capture information about themselves and share it with friends, family and health and care professionals. The personalised care and support plans include an ‘urgent care plan’ which, building on integration with London NHS111 services, gives the emergency and out-of-hours services real-time access to information to help ensure the appropriate pathway is chosen, avoiding A&E admissions where possible.
“UCLPartners is delighted to see IXICO awarded this funding, as it will help to take their work to the next level,” saidProfessor Joanne Hackett, Commercial Director of UCLPartners, “This is the kind of work we are especially keen to support as it has the potential to improve the standard of care for so many people.”
SBRI Healthcare works with leading healthcare organisations to identify areas where technology can be applied to address major healthcare challenges. The 14 successful projects have been selected on their potential value to the health service and on the improved outcomes delivered to patients. The companies will be supported and fully funded to demonstrate the technical feasibility of their proposed concept and those businesses demonstrating best value and greatest technical feasibility in phase 1 will progress through to phase 2 to be further supported and funded to take their technologies through to commercialisation.
To find out more, visit www.sbrihealthcare.co.uk
Established in 2004, IXICO develops innovative technologies to help those involved in researching and treating serious diseases to make rapid decisions and improve patient outcomes.